This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Education and support during the shared decision-making process is key to ensuring that people with haemophilia are able to make informed therapeutic choices as gene therapy becomes more widely available as a treatment option
Figure 1.
The patient decision-making journey in the current treatment landscape (cf. Wang et al., 2022) [19]